ICD10 code of Wernicke-Korsakoff Syndrome and ICD9 code

Wernicke-Korsakoff Syndrome is clinically classified under the ICD-10 code E51.2, while its historical ICD-9 designation is 265.1. These codes represent a serious neurological condition caused by a severe deficiency of thiamine (vitamin B1), which requires immediate medical intervention to prevent permanent brain damage.

What is the clinical significance of Wernicke-Korsakoff Syndrome?

Wernicke-Korsakoff Syndrome is a two-stage brain disorder that occurs when the brain is deprived of thiamine for an extended period. The first stage, Wernicke’s encephalopathy, is an acute medical emergency characterized by confusion, ataxia (lack of voluntary coordination of muscle movements), and ophthalmoplegia (paralysis of eye muscles). If left untreated, it often progresses to the second stage, Korsakoff’s syndrome, which is a chronic, debilitating condition primarily affecting memory and cognitive function. Currently, 11 members within the Wernicke-Korsakoff Syndrome community on DiseaseMaps.org have shared their personal experiences, highlighting the importance of early diagnosis and nutritional support in managing the long-term impacts of the disease.

How is Wernicke-Korsakoff Syndrome diagnosed and coded?

Diagnosis of Wernicke-Korsakoff Syndrome is primarily clinical, meaning physicians look for the classic triad of symptoms rather than relying on a single blood test. Because the disease is often under-recognized, clinicians use specific coding to track patient care and outcomes. The ICD-10 code E51.2 is the current global standard for identifying Wernicke-Korsakoff Syndrome in electronic health records, while the ICD-9 code 265.1 remains in older medical literature and legacy data systems. Accurate coding is vital for ensuring that patients receive appropriate treatment, including high-dose parenteral thiamine replacement, which is the cornerstone of clinical management.

What are the primary complications of Wernicke-Korsakoff Syndrome?

The transition from the acute phase to the chronic phase of Wernicke-Korsakoff Syndrome leads to significant cognitive shifts. Patients and caregivers should be aware of the following common clinical manifestations associated with the progression of the condition:

• Anterograde amnesia: The inability to form new memories after the onset of the condition.


• Confabulation: The brain creating "honest lies" or invented memories to fill gaps in recollection.


• Ataxia: Persistent balance and gait disturbances that increase the risk of falls.


• Executive dysfunction: Difficulty with planning, organizing, and completing complex tasks.


• Apathy: A significant lack of motivation or emotional response, which can be mistaken for depression.

Is Wernicke-Korsakoff Syndrome reversible?

The reversibility of Wernicke-Korsakoff Syndrome depends almost entirely on the timing of thiamine administration. While the acute symptoms of Wernicke’s encephalopathy can often be reversed with prompt, aggressive intravenous thiamine therapy, the memory impairments associated with Korsakoff’s syndrome are often permanent or only partially responsive to treatment. Early detection is the most important factor in preventing the transition to the chronic stage. Clinical researchers emphasize that even after the initial stabilization of Wernicke-Korsakoff Syndrome, patients require long-term nutritional monitoring and, in many cases, supportive psychological and cognitive rehabilitation to adapt to neurological changes.

Next steps

• Consult a neurologist or a specialized metabolic physician immediately if you suspect symptoms of thiamine deficiency.


• Request a comprehensive nutritional panel to assess vitamin B1 levels if you are at high risk due to malabsorption or dietary factors.


• Join the Wernicke-Korsakoff Syndrome community on DiseaseMaps.org to connect with others who are navigating the same diagnostic and recovery pathways.


• Work with a clinical neuropsychologist to develop cognitive strategies for managing memory gaps and executive dysfunction.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• National Institutes of Health (NIH) - Genetic and Rare Diseases Information Center (GARD): Wernicke-Korsakoff Syndrome.


• Orphanet: Wernicke-Korsakoff syndrome (ORPHA:96144).


• OMIM (Online Mendelian Inheritance in Man): Entry #277730 (Wernicke-Korsakoff syndrome).


• World Health Organization (WHO): International Classification of Diseases, 10th Revision (ICD-10).